Glaxo SmithKline Pakistan Limited
Financial Results for the Year Ended December 31, 2021 GlaxoSmithKline Pakistan Limited
The Board of Directors of our Company in their meeting held on 25 February 2022, at GSK Pakistan Limited, 35-Dockyard Road, West Wharf, Karachi, recommended the following:
(i) CASH DIVIDEND
A final Cash Dividend for the year ended December 31, 2021 at Rs. 7 per share i.e. 70%.
(ii) BONUS SHARES NIL
The 75th Annual General Meeting of the Company will be held on 25 April 2022 at 11:00 a.m.
*The above entitlement will be paid to the shareholders whose names will appear in the Register of Members on 18 April 2022.
The Share Transfer Books of the Company will be closed from 19 April 2022 to 25 April 2022 (both days inclusive). Transfer requests received at the office of the Share Registrar of the Company at CDC Share Registrar Services Limited, CDC House, 99-B, Block-B, S.M.C.H.S., Main Shahrah-e-Faisal, Karachi - 74000 at the close of business on 18 April 2022 will be treated in time for the purpose of above entitlement to the transferees.
The Annual Report of the Company will be transmitted through PUCARS at least twenty (21) days before holding of the Annual General Meeting.
Post a Comment